103 related articles for article (PubMed ID: 7594563)
21. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
[TBL] [Abstract][Full Text] [Related]
22. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis.
Giudice GJ; Wilske KC; Anhalt GJ; Fairley JA; Taylor AF; Emery DJ; Hoffman RG; Diaz LA
J Invest Dermatol; 1994 Jun; 102(6):878-81. PubMed ID: 7516396
[TBL] [Abstract][Full Text] [Related]
23. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
[TBL] [Abstract][Full Text] [Related]
24. Development of an ELISA for the detection of autoantibodies to BP230.
Kromminga A; Sitaru C; Hagel C; Herzog S; Zillikens D
Clin Immunol; 2004 Apr; 111(1):146-52. PubMed ID: 15093564
[TBL] [Abstract][Full Text] [Related]
25. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain.
Balding SD; Prost C; Diaz LA; Bernard P; Bedane C; Aberdam D; Giudice GJ
J Invest Dermatol; 1996 Jan; 106(1):141-6. PubMed ID: 8592065
[TBL] [Abstract][Full Text] [Related]
26. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.
Zillikens D; Rose PA; Balding SD; Liu Z; Olague-Marchan M; Diaz LA; Giudice GJ
J Invest Dermatol; 1997 Oct; 109(4):573-9. PubMed ID: 9326393
[TBL] [Abstract][Full Text] [Related]
27. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
[TBL] [Abstract][Full Text] [Related]
28. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
Leighty L; Li N; Diaz LA; Liu Z
Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning of a cDNA encoding the porcine type XVII collagen noncollagenous 16 A domain and localization of the domain to the upper part of porcine skin basement membrane zone.
Xu L; Olivry T; Chan LS
Vet Dermatol; 2004 Jun; 15(3):146-51. PubMed ID: 15214950
[TBL] [Abstract][Full Text] [Related]
30. A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies.
Nishie W; Sawamura D; Natsuga K; Shinkuma S; Goto M; Shibaki A; Ujiie H; Olasz E; Yancey KB; Shimizu H
J Immunol; 2009 Sep; 183(6):4088-93. PubMed ID: 19717520
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients.
Di Zenzo G; Grosso F; Terracina M; Mariotti F; De Pità O; Owaribe K; Mastrogiacomo A; Sera F; Borradori L; Zambruno G
J Invest Dermatol; 2004 Jan; 122(1):103-10. PubMed ID: 14962097
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
[TBL] [Abstract][Full Text] [Related]
33. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
[TBL] [Abstract][Full Text] [Related]
34. Antiplectin autoantibodies in subepidermal blistering diseases.
Buijsrogge JJ; de Jong MC; Kloosterhuis GJ; Vermeer MH; Koster J; Sonnenberg A; Jonkman MF; Pas HH
Br J Dermatol; 2009 Oct; 161(4):762-71. PubMed ID: 19566666
[TBL] [Abstract][Full Text] [Related]
35. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.
Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619
[TBL] [Abstract][Full Text] [Related]
36. Experimental animal models of bullous pemphigoid.
Heimbach L; Li N; Diaz A; Liu Z
G Ital Dermatol Venereol; 2009 Aug; 144(4):423-31. PubMed ID: 19755945
[TBL] [Abstract][Full Text] [Related]
37. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.
Liu Z; Shipley JM; Vu TH; Zhou X; Diaz LA; Werb Z; Senior RM
J Exp Med; 1998 Aug; 188(3):475-82. PubMed ID: 9687525
[TBL] [Abstract][Full Text] [Related]
38. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
Sugi T; Hashimoto T; Hibi T; Nishikawa T
J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
[TBL] [Abstract][Full Text] [Related]
39. A major role for neutrophils in experimental bullous pemphigoid.
Liu Z; Giudice GJ; Zhou X; Swartz SJ; Troy JL; Fairley JA; Till GO; Diaz LA
J Clin Invest; 1997 Sep; 100(5):1256-63. PubMed ID: 9276744
[TBL] [Abstract][Full Text] [Related]
40. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.
Chen R; Ning G; Zhao ML; Fleming MG; Diaz LA; Werb Z; Liu Z
J Clin Invest; 2001 Oct; 108(8):1151-8. PubMed ID: 11602622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
